Director TitleAgeSince
Chairman - -
Chairman - 28/06/2012
Director/Board Member - 24/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
-4.83%+3.51%+55.00%+62.02% 66.7B
+4.46%+8.70%+14.36%+85.06% 56.88B
+1.06%+3.49%+25.62%+97.76% 56.53B
+5.09%+9.89%+27.19%+103.27% 46.49B
+2.62%+1.68%+29.16%+36.08% 44.8B
+8.24%+0.51%+215.16%+807.84% 41.59B
-1.86%+10.13%+28.14%+53.61% 35.35B
+3.83%-0.95%+95.31%+66.88% 33.29B
+5.19%+1.62%-39.69%+381.71% 25.1B
Average +2.50%+2.65%+50.03%+188.25% 45.19B
Weighted average by Cap. +2.16%+3.07%+50.71%+167.72%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock